Medical Weight Loss for Levittown, New York Residents

Levittown, New York residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.

Physician-supervised GLP-1 programs from $166/month, serving Levittown through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.

Serving Levittown, New York by telehealth: your consultation, prescription, and follow-ups all happen by secure video, with compounded medication shipped to your door. Our only physical clinic is in Costa Mesa, California; everything else is virtual. Doctor review just $119 (medication separate).

Why Levittown Residents Choose New Hope Weight Loss

At New Hope Weight Loss, every case in Levittown is overseen by a named physician, Dr. Anjmun Sharma, MD. You are not handed off to a rotating panel of strangers or a faceless intake bot. Dr. Sharma reviews your history, signs off on your plan, and stays accountable for it. That single point of medical responsibility is rare in telehealth, and it is the reason so many people across New York trust us to guide a serious decision about their health.

Levittown is part of the area New Hope Weight Loss serves by telehealth. The same compounded semaglutide and tirzepatide protocols, the same flat pricing, and the same bilingual support reach Levittown patients at home.

Patients in Levittown get the identical physician-supervised treatment that someone walking into our Costa Mesa office would get, all of it handled by telehealth so New York residents never have to travel. We care for patients throughout Levittown and the greater Nassau County area of Long Island. Every prescription is reviewed and authorized by Dr. Anjmun Sharma, MD, before anything is sent to your address in New York.

Getting started in New York takes a short physician visit by video this week, not a referral, a waitlist, or a trip to an office. Between Klarna, Affirm, and HSA or FSA cards, Levittown patients have several ways to handle the $119 review and ongoing medication payments. New York is among the most populous states in the nation, and New Hope Weight Loss serves patients across it, from the city to upstate, by secure telehealth from our Costa Mesa, California clinic.

GLP-1 Weight Loss Programs Available

Compounded GLP-1 care, supervised by a physician

The 90-Day Metabolic Reset is built on semaglutide, the same active ingredient you will find in Wegovy and Ozempic. It is priced from $166/mo, with the complete 90-day program at $499, and branded-drug trials averaged about 15 to 17 percent body-weight loss. Compounded semaglutide is not FDA-approved, not brand-identical, and results vary by person. Dr. Sharma manages your care by telehealth, wherever you are in Levittown.

Prefer the dual-action route? Tirzepatide

From $233/mo, tirzepatide works on GLP-1 and GIP together. In branded-drug trials, dose-qualified patients reached up to 22.5 percent loss, a peak number that is not typical. Same active ingredient as Mounjaro and Zepbound.

It all starts with a $119 physician review. Medication billed separately. HSA, FSA, Klarna, and Affirm accepted.

How Telehealth Works for Levittown

Here is what to expect, step by step, from anywhere in Levittown.

Step 1. Fill out a quick intake quiz about your weight, health history, and goals.

Step 2. Dr. Anjmun Sharma reviews your intake and meets you by secure video, usually within 48 hours, to decide whether compounded semaglutide or tirzepatide is right for you.

Step 3. If she prescribes, a state-licensed 503(a) pharmacy ships your medication to your Levittown address in cold-pack packaging.

Step 4. You keep going with video follow-ups, no office visit required, anywhere in .

Frequently Asked Questions, Levittown

I am searching for weight loss care near Levittown. Where are you?

We are based in Costa Mesa, California, where our only physical clinic operates. Patients in Levittown, New York connect with us by telehealth instead of visiting. Dr. Anjmun Sharma conducts a video consult to review your goals and confirm whether you qualify for a compounded GLP-1 medication program.

Do I need to be seen in person if I live in Levittown?

Not at all. The telehealth format covers Levittown patients from start to finish, so no clinic visit is ever required. You speak with Dr. Sharma by video, and once you are approved, compounded medication ships to Levittown in cold-pack packaging built to keep it cool and stable.

What are the program costs for Levittown patients?

The physician review is priced at $119. Compounded semaglutide is available from $166 a month or $499 for the 90-day plan, and tirzepatide from $233 a month. Medication is invoiced separately. Payment options include HSA, FSA, Klarna, and Affirm, and Levittown patients face no distance surcharge.

What areas of Levittown do you serve?

We serve patients from across Levittown by telehealth, including Levittown and the greater Nassau County area of Long Island.

How does compounded medication compare on cost for Levittown patients?

Compounded semaglutide from $166/month and tirzepatide from $233/month are a fraction of typical brand-name cash prices. Levittown patients see flat pricing up front, and compounded semaglutide and tirzepatide are not FDA-approved or brand-identical, which Dr. Sharma reviews with you.

Levittown Residents, Get Started Today

Doctor review $119. Semaglutide from $166/mo. Tirzepatide from $233/mo. Medication separate.

Start My Journey →

New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Levittown, New York by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.

Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.